Compounds with medicinal effects due to interaction with the glucocorticoid receptor
Details for Australian Patent Application No. 2006328550 (hide)
International Classifications
Event Publications
26 June 2008 PCT application entered the National Phase
PCT publication WO2007/071638 Priority application(s): WO2007/071638
22 December 2011 Alteration of Name
The name of the applicant has been altered to MSD Oss B.V. 2007
5 April 2012 Corrigenda
Change of Names(s) of Applicant(s), Section 104 - 2006 Under the name MSD Oss B.V., Application No. 2006328550, Under INID (71), Correct the applicant name to MSD Oss B.V. and Pharmacopeia L.L.C.
12 April 2012 Application Accepted
Published as AU-B-2006328550
9 August 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006328551-Substituted pyrazinone derivatives as alpha2c-adrenoreceptor antagonists
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser